New Scientist: The biggest buzz is around Medicon Valley
In the special annual feature ‘Scandinavia Biopharma’ the magazine New Scientist portrays Scandinavian life science in regards to cluster profiles and job opportunities.
The feature profiles the key places to work in biotechnology and pharmaceuticals and in their opinion Medicon Valley is the most attractive life science cluster in Scandinavia. The reason for this is the presence of more than 300 life science companies, a labour force fuelled by the region’s 12 universities, many job opportunities, a family friendly Scandinavian culture and a pleasant work environment. The feature contains practical advice and information relevant to jobseekers at any stage of their scientific and technological careers.
The feature contains practical and useful advices and information relevant to jobseekers at any stage of their scientific and technological careers.
Below you will find the opening of the article. Click here to read the full article.
|
Design for Nordic living
|
|
The adventures that only fledgling biopharma industries can offer - plus the very different attractions of the family-friendly Scandinavian culture - more than offset a few dark winter days and hefty taxes, says Nancy Bazilchuk
Scandinavia’s multimillion-euro biotechnology and pharmaceutical industry has its roots in Sweden and Denmark, where regional leaders such as Novo Nordisk started life in the 1920s as two separate companies selling then revolutionary insulin.
The numbers reflect that maturity. In a recent OECD survey of patent statistics, Denmark led the world in the number of biotech patents filed as a percentage of the national total, while Sweden and Denmark have both increased biotech patent applications to the European Patent Office by 7 per cent…
Source: New Scientist, 05.05.2007.
|